Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page
- Check2 days agoChange DetectedA new May 2026 revision entry (v3.5.4) was added to the study record, replacing the prior April 2026 revision (v3.5.3).SummaryDifference0.2%

- Check9 days agoChange DetectedRelated topics now include 'Multiple myeloma' and 'MedlinePlus Genetics'. These additions connect the study page to disease information and genetics resources.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page's revision label updated to v3.5.3, reflecting a minor update to the page's underlying implementation. The change does not modify the study details or user-facing content.SummaryDifference0.0%

- Check23 days agoChange DetectedRemoved “Multiple myeloma” related-topic links (including MedlinePlus Genetics).SummaryDifference0.1%

- Check31 days agoChange DetectedOn 2026-04-13, the record was updated with new topics (Multiple myeloma) and locations (Novant Health Charlotte, Tennessee Oncology Chattanooga, Texas Oncology P A 1) and related link (MedlinePlus Genetics); earlier sites (Novant Health, Tennessee Oncology, Texas Oncology P A) were removed, and revision updated to v3.5.2.SummaryDifference0.3%

- Check38 days agoChange DetectedRemoved the condition 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the study page.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.